EXPLORE MORE CATEGORIES
- Home
- »
- Our Products
- »
- Pharmaceutical Injections - 1
Pharmaceutical Injections - 1
Our product range includes a wide range of hydroxocobalamin injection(trineurosol hp injection 1000mcg/ml), zoledronic acid injection, etomidate injection (hypnodate 2mg/ml injection), lox 2% ( lidocaine) injection, zoledronic acid 4 mg injection (zolasta3 4mg injection) and insulin glargine injection.
Hydroxocobalamin Injection(Trineurosol HP Injection 1000mcg/Ml)
Product Price: Rs 15 / PieceGet Best Price
Minimum Order Quantity: 10 Piece
Product Brochure
Product Details:
| Strength | 1000mcg |
| Pack Size | 2 ml |
| Pack Type | Vial |
| Drug Composition | Methylcobalamin 1000mcg |
| Brand Name | Trineurosol |
| Shelf Life | 36 Months |
Hydroxocobalamin Injection (Trineurosol HP Injection 1000 mcg/mL)
Overview: Hydroxocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency and certain types of cyanide poisoning. It is administered via injection.
Uses:
- Vitamin B12 Deficiency: Treats deficiencies that can lead to anemia and neurological issues.
- Cyanide Poisoning: Acts as an antidote in cases of cyanide exposure.
- Dietary Supplement: Used in individuals with absorption issues or specific dietary needs.
Dosage:
- Typical Dose: Varies based on the condition. For vitamin B12 deficiency, a common regimen may start with 1000 mcg intramuscularly, with adjustments made based on lab results.
- Administration: Administered by a healthcare professional, typically via intramuscular or intravenous injection.
Mechanism of Action:
Hydroxocobalamin works by:
- Replenishing vitamin B12 levels in the body.
- Facilitating the conversion of homocysteine to methionine, which is crucial for DNA synthesis and neurological function.
Side Effects:
- Common: Injection site reactions, headache, dizziness, nausea, and gastrointestinal discomfort.
- Serious: Allergic reactions (rare), which can include difficulty breathing, swelling, or rash. Seek immediate medical attention if these occur.
Precautions:
- Allergies: Inform your healthcare provider of any allergies, especially to cobalt or other vitamin B12 formulations.
- Medical History: Discuss any history of Leber’s disease (a hereditary optic neuropathy) or other health issues with your provider.
Contraindications:
- Known hypersensitivity to hydroxocobalamin or any component of the injection.
Drug Interactions:
- May interact with certain medications, including those that affect absorption (e.g., proton pump inhibitors) or medications that affect blood clotting. Always inform your healthcare provider of all medications you are taking.
Storage:
- Store at room temperature, away from moisture and light. Protect from freezing. Keep out of reach of children.
Patient Counseling:
- Ensure proper injection technique is followed if self-administering.
- Discuss potential side effects and the importance of adhering to the prescribed treatment plan.
- Monitor for signs of deficiency or adverse reactions, and report any concerns to your healthcare provider.
Conclusion:
Hydroxocobalamin Injection (Trineurosol HP) is an effective treatment for vitamin B12 deficiency and a critical intervention for cyanide poisoning. Proper administration, monitoring, and patient education are essential for safe and effective use. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Zoledronic Acid Injection
Product Price: Rs 2,500 / VialGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 4 mg |
| Packaging Size | 5 ml |
| Manufacturer | Zee Laboratories Ltd |
| Brand Name | Nuways |
| Treatment | Osteoporosis |
Zoledronic Acid 4 mg/5 ml Injection (Zoldric 4 mg/5 ml Injection)
Indications:
Zoledronic acid is indicated for the treatment and prevention of osteoporosis in postmenopausal women, for the treatment of glucocorticoid-induced osteoporosis in men and women, and for the treatment of Paget's disease of bone. It is also used in patients with bone metastases from solid tumors and in multiple myeloma to prevent skeletal-related events.
Mechanism of Action:
Zoledronic acid is a bisphosphonate that inhibits osteoclast-mediated bone resorption, leading to a decrease in bone turnover and a subsequent increase in bone mineral density. This action helps to reduce the risk of fractures and other skeletal-related events.
Dosage and Administration:
- Dosage: The recommended dose of zoledronic acid is typically 4 mg administered as an intravenous infusion once a year for osteoporosis, or as directed for other indications.
- Administration: Administer via intravenous infusion over at least 15 minutes. Ensure proper hydration before administration.
Contraindications:
- Hypersensitivity to zoledronic acid or any component of the formulation.
- Patients with severe renal impairment (creatinine clearance <30 mL/min).
Warnings and Precautions:
- Renal Function: Monitor renal function prior to each dose and periodically during treatment. Dose adjustments may be necessary for patients with renal impairment.
- Hypocalcemia: Correct hypocalcemia prior to treatment, as zoledronic acid can exacerbate this condition.
- Osteonecrosis of the Jaw: Patients should be assessed for dental issues and receive appropriate dental care before initiating treatment.
Side Effects:
Common side effects may include:
- Fatigue
- Nausea
- Fever
- Bone pain
- Headache
Serious side effects can include:
- Renal impairment
- Osteonecrosis of the jaw
- Severe allergic reactions
Drug Interactions:
Zoledronic acid may interact with other medications that affect renal function or electrolyte balance. Patients should inform their healthcare provider of all medications they are taking.
Storage:
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:
- Advise patients to report any signs of jaw pain, swelling, or dental problems, as these may indicate osteonecrosis of the jaw.
- Discuss the importance of adhering to the treatment schedule and attending regular follow-up appointments for monitoring renal function and bone health.
- Encourage patients to maintain adequate hydration and a balanced diet rich in calcium and vitamin D.
Conclusion:
Zoledronic acid is an effective treatment for osteoporosis and related conditions, providing patients with a means to improve bone health and reduce fracture risk. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Etomidate Injection (Hypnodate 2mg/ml Injection)
Product Price: Rs 225 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 20 mg/ 10 ml |
| Dose/Strength | 2 mg/ml |
| Pack Size | 10 ml |
| Composition | Etomidate 2 mg/ml |
| Brand Name | Hypnodate |
| Manufacturer By | Neon Laboratories Ltd |
| Usage/Application | General Anesthesia |
Overview: Etomidate is an injectable anesthetic agent known for its rapid onset and short duration of action. It is primarily used for the induction of general anesthesia and sedation in various medical procedures.
Indications for UseHypnodate 2 mg/mL Injection is indicated for:
- Induction of Anesthesia: Used for rapid induction of general anesthesia, especially in patients with cardiovascular instability.
- Procedural Sedation: Provides sedation for short procedures or for patients requiring sedation in critical care settings.
Etomidate works by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor. This results in CNS depression, leading to sedation and loss of consciousness.
Dosage and Administration- Dosage: Typical adult induction doses range from 0.1 to 0.3 mg/kg, administered intravenously. The specific dose should be determined by the healthcare provider based on the patient’s condition and response.
- Administration Route: Given via slow intravenous injection.
Common Side Effects:
- Pain or discomfort at the injection site
- Dizziness or sedation
- Nausea
Serious Side Effects:
- Adrenal suppression: Prolonged use may inhibit adrenal gland function, leading to decreased cortisol production.
- Allergic reactions (rare)
- Use with caution in patients with known adrenal insufficiency or those at risk for adrenal suppression.
- Continuous monitoring of vital signs is essential during and after administration.
- Ensure resuscitation equipment is available, as etomidate can cause respiratory depression in sensitive individuals.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be advised to:
- Inform healthcare providers about any allergies, especially to medications.
- Discuss any medical conditions, particularly adrenal issues, before administration.
- Understand that sedation may affect their ability to perform tasks afterward and that assistance may be needed.
Etomidate Injection (Hypnodate 2 mg/mL) is a valuable agent for the induction of anesthesia and procedural sedation. Proper administration, monitoring, and patient education are crucial for ensuring safety and effectiveness during medical procedures. Always consult a healthcare professional for personalized guidance regarding its use.
Yes! I am InterestedRequest A Callback
Lox 2% ( Lidocaine) Injection
Product Price: Rs 20 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 2% w/v |
| Packaging Size | 30ml |
| Composition | Lidocaine 2% w/v |
| Brand | Lox |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Local Anesthesia |
Overview: Lox 2% is a formulation of lidocaine, a local anesthetic commonly used to provide temporary pain relief during various medical procedures. The 2% concentration is effective for a range of applications in both local and regional anesthesia.
Indications for UseLox 2% is indicated for:
- Local Anesthesia: Suitable for minor surgical procedures, dental work, and diagnostic tests.
- Regional Anesthesia: Often used in nerve blocks and epidurals for more extensive pain management.
Lidocaine works by blocking sodium channels in nerve membranes, inhibiting the propagation of nerve impulses. This results in a loss of sensation in the targeted area, providing effective pain relief.
Dosage and Administration- Dosage: The specific dosage depends on the procedure and patient factors. Administered by a healthcare professional, typically through injection.
- Administration Techniques: Can be given locally or in regional blocks, depending on the intended effect.
Common Side Effects:
- Localized swelling or redness at the injection site
- Dizziness or lightheadedness
Serious Side Effects:
- Allergic reactions (rare)
- Systemic toxicity (e.g., seizures, cardiac issues) if absorbed in significant amounts
- Neurological symptoms such as tingling or numbness
- Use with caution in patients with allergies to local anesthetics or those with certain medical conditions (e.g., heart issues, neurological disorders).
- Monitor for signs of toxicity, particularly with higher doses or in sensitive populations.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be advised to:
- Report any unusual symptoms or side effects to their healthcare provider.
- Understand the procedure and what to expect regarding pain relief and recovery.
Lox 2% (Lidocaine) Injection is an effective local anesthetic for various medical applications. Proper use, monitoring, and patient education are essential to ensure safety and effectiveness. Always consult a healthcare professional for specific advice regarding its administration.
Yes! I am InterestedRequest A Callback
Zoledronic Acid 4 mg Injection (Zolasta3 4mg Injection)
Product Price: Rs 1,550 / VialGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 4 mg |
| Packaging Size | 1 Injection in 1 vial |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Brand Name | Zolasta |
| Uses | Osteoporosis |
Zoledronic Acid Injection (Zolasta 4 mg)
Indications:
Zoledronic acid is indicated for the treatment and prevention of osteoporosis in postmenopausal women and men, for the treatment of glucocorticoid-induced osteoporosis, for Paget's disease of bone, and to prevent skeletal-related events in patients with bone metastases from solid tumors and in multiple myeloma.
Mechanism of Action:
Zoledronic acid is a bisphosphonate that inhibits osteoclast-mediated bone resorption. By decreasing bone turnover, it helps increase bone mineral density and reduces the risk of fractures and skeletal-related events.
Dosage and Administration:
Dosage: The recommended dose is typically 4 mg administered as an intravenous infusion once a year for osteoporosis, or as specified for other indications.
Administration: Administer via intravenous infusion over at least 15 minutes. Ensure proper hydration before administration.
Contraindications:
Hypersensitivity to zoledronic acid or any component of the formulation.
Severe renal impairment (creatinine clearance <30 mL/min).
Warnings and Precautions:
Renal Function: Monitor renal function before each dose and periodically during treatment. Dose adjustments may be necessary for patients with renal impairment.
Hypocalcemia: Correct hypocalcemia prior to treatment, as zoledronic acid can exacerbate this condition.
Osteonecrosis of the Jaw: Patients should be assessed for dental issues and receive appropriate dental care before initiating treatment.
Side Effects:
Common side effects may include:
Fatigue
Nausea
Fever
Bone pain
Headache
Serious side effects can include:
Renal impairment
Osteonecrosis of the jaw
Severe allergic reactions
Drug Interactions:
Zoledronic acid may interact with other medications affecting renal function or electrolytes. Patients should inform their healthcare provider of all medications they are taking.
Storage:
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:
Advise patients to report any signs of jaw pain, swelling, or dental problems, which may indicate osteonecrosis of the jaw.
Discuss the importance of adhering to the treatment schedule and attending regular follow-up appointments for monitoring renal function and bone health.
Encourage patients to maintain adequate hydration and a balanced diet rich in calcium and vitamin D.
Conclusion:
Zoledronic acid is an effective treatment for osteoporosis and related conditions, improving bone health and reducing fracture risk. Continuous communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Insulin Glargine Injection
Product Price: Rs 2,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 100 IU/ml |
| Form | Injection |
| Packaging Type | Box |
| Shelf Life | 2 Years |
| Prescription/Non prescription | Prescription |
Yes! I am InterestedRequest A Callback
Zolistra Zoledronic Acid 4mg Injectiion
Product Price: Rs 375 / PieceGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 4 mg |
| Packaging Type | Vial |
| Composition | Zoledronic Acid 4mg Injectiion |
| Manufacturer | Celon Laborataries |
| Usage/Application | Hospital |
| Shelf Life | 24 to 36 Month |
| Brand Name | Zolistra |
Overview: Zoledronic acid is a bisphosphonate medication primarily used to treat various conditions related to bone health. It helps to inhibit bone resorption and is used in the management of osteoporosis, Paget's disease, and certain types of cancer that affect the bones.
Uses:- Osteoporosis: Used to increase bone mineral density and reduce the risk of fractures in postmenopausal women and men.
- Paget's Disease of Bone: Helps in the treatment of this chronic disorder that can result in enlarged and deformed bones.
- Bone Metastases: Used in patients with cancers such as breast cancer and prostate cancer to prevent skeletal-related events (e.g., fractures).
- Hypercalcemia of Malignancy: Used to treat elevated calcium levels in the blood due to cancer.
- Typical Dose: The standard dose for osteoporosis is usually 5 mg administered intravenously once a year. For other indications, the dose may vary; for example, 4 mg for treating hypercalcemia or bone metastases, given as a single infusion.
- Administration: Administered as an intravenous infusion over a period of at least 15 minutes. Adequate hydration is recommended before administration.
Zoledronic acid works by:
- Inhibiting osteoclast-mediated bone resorption, which decreases the rate of bone turnover and helps maintain bone density.
- Common: Fever, fatigue, nausea, vomiting, and bone pain.
- Serious: Risk of osteonecrosis of the jaw, renal impairment, and severe allergic reactions. Regular monitoring of kidney function is important.
- Renal Function: Assess renal function before administration, as zoledronic acid can affect kidney function. Avoid in patients with severe renal impairment.
- Dental Health: Patients should have a dental examination prior to treatment due to the risk of osteonecrosis of the jaw.
- Known hypersensitivity to zoledronic acid or any components of the formulation.
- Severe renal impairment (e.g., creatinine clearance < 30 mL/min).
- May interact with other medications affecting renal function. Always inform your healthcare provider of all medications being taken.
- Store at room temperature, away from light and moisture. Keep out of reach of children.
- Follow the prescribed treatment schedule and do not miss appointments for infusions.
- Stay well-hydrated before and after the infusion.
- Report any signs of severe side effects, such as jaw pain or swelling, difficulty in swallowing, or signs of kidney issues, to your healthcare provider.
Zolistra (Zoledronic Acid 4 mg Injection) is an effective treatment for managing bone health in various conditions, including osteoporosis and cancer-related bone issues. Proper administration, monitoring, and patient education are essential for optimal outcomes. Always consult your healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Lignocaine ( Lox Heavy 5% ) Injection
Product Price: Rs 850 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 2% w/v |
| Packaging Size | 30ml |
| Dose/Strength | 5% |
| Pack size | 10*5*2 ml |
| Composition (Salt) | Lidocaine 5% w/v |
| Brand Name | Lox Heavy |
| Manufacturer By | Neon Laboratories Ltd |
| Treatment | Local anesthesia |
Overview: Lignocaine, also known as lidocaine, is a widely used local anesthetic that provides pain relief for various medical procedures. Lox Heavy 5% refers to a concentrated formulation containing 5% lignocaine, ideal for more extensive anesthetic needs.
Indications for UseLignocaine (Lox Heavy 5%) is primarily indicated for:
- Local Anesthesia: Suitable for minor surgical procedures and dental work.
- Regional Anesthesia: Used in techniques such as epidurals or nerve blocks for surgeries, particularly in the lower body.
Lignocaine works by blocking sodium channels in nerve membranes, inhibiting the propagation of nerve impulses. This action results in localized numbness, effectively reducing pain in the treated area.
Dosage and Administration- Dosage: Administered via injection. The specific dosage will depend on the procedure and the individual patient's needs.
- Administration Techniques: Can be given locally or in regional blocks, depending on the site and extent of anesthesia required.
Common Side Effects:
- Localized swelling or redness at the injection site
- Dizziness or lightheadedness
Serious Side Effects:
- Allergic reactions (rare)
- Systemic toxicity (e.g., seizures, cardiac issues) if absorbed in significant amounts
- Neurological symptoms like tingling or numbness
- Use cautiously in patients with known allergies to local anesthetics or those with specific medical conditions (e.g., heart issues, neurological disorders).
- Monitor patients for signs of toxicity, particularly with higher doses.
- Store at room temperature, away from light.
- Keep out of reach of children.
Patients should be informed to:
- Report any unusual symptoms or side effects to their healthcare provider.
- Understand the procedure and anticipated pain management.
Lignocaine (Lox Heavy 5%) Injection is an effective local anesthetic for various medical applications. Proper use, monitoring, and patient education are essential to maximize safety and effectiveness. Always consult a healthcare professional for specific advice and guidance regarding its administration.
Yes! I am InterestedRequest A Callback
Ferric Carboxymaltose Injection (orofer Fcm 500mg / 10ml Injection)
Product Price: Rs 2,260 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 500 mg |
| Packaging Type | Single Use Vial |
| Brand Name | Orofer FCM |
| Composition | Ferric Carboxymaltose 500mg / 10ml |
| Manufacturer | Emcure |
| Country of Origin | Made in India |
| Treatment | Lack Of Iron Paleness |
Indications: Ferric carboxymaltose is indicated for:
- Treatment of iron deficiency anemia in adults, particularly in those who have chronic kidney disease (CKD) or are undergoing hemodialysis.
- Management of iron deficiency when oral iron supplementation is inadequate or not tolerated.
Mechanism of Action: Ferric carboxymaltose is an intravenous iron preparation. It provides a source of iron, which is essential for the synthesis of hemoglobin and the formation of red blood cells, thereby improving iron levels and correcting anemia.
Dosage and Administration:
- Typical Dosage: The usual dose for adults is 500 mg (10 mL) administered intravenously. The dosage may vary based on the patient's iron levels and clinical condition.
- Administration: Ferric carboxymaltose can be given as a slow intravenous injection or infusion. The injection should be administered by a healthcare professional.
Side Effects:
- Common: Nausea, vomiting, abdominal pain, and headache.
- Serious: Hypersensitivity reactions (including anaphylaxis), hypotension, and iron overload.
Contraindications:
- Known hypersensitivity to ferric carboxymaltose or any component of the formulation.
- Patients with iron overload syndromes (e.g., hemochromatosis) or non-iron deficiency anemia.
Warnings and Precautions:
- Hypersensitivity: Monitor patients closely for signs of allergic reactions during and after administration.
- Iron Overload: Assess iron status prior to administration and periodically during treatment.
- Injection Site Reactions: Monitor for local reactions at the injection site.
Drug Interactions: Ferric carboxymaltose may interact with other medications, particularly those that affect iron metabolism or may lead to iron overload. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F). Protect from light and do not freeze.
Patient Counseling Information:
- Advise patients to report any signs of allergic reactions or severe side effects immediately.
- Discuss the importance of follow-up appointments to monitor iron levels and overall health.
Ferric Carboxymaltose Injection (Orofer FCM 500 mg/10 mL) is an effective treatment for iron deficiency anemia, particularly in specific patient populations. It’s important for patients to be monitored closely during treatment and to communicate any concerns with their healthcare providers. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
11.25 Mg Leuprolide Acetate Injection
Product Price: Rs 9,750 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 11.25 mg |
| Packaging Type | Vial |
| Form | Injection |
| Composition | Leuprolide (11.25mg) |
| Storage | Store in a refrigerator (2 - 8 DegreeC) |
Overview:
11.25mg Leuprolide Acetate Injection contains Leuprolide Acetate, a gonadotropin-releasing hormone (GnRH) agonist used in the treatment of prostate cancer, endometriosis, uterine fibroids, and precocious puberty. Leuprolide works by suppressing the production of sex hormones (testosterone and estrogen) through continuous stimulation of the GnRH receptor, leading to a temporary reduction in hormone levels.
Indications:
11.25mg Leuprolide Acetate Injection is indicated for:
- Prostate Cancer: Treatment of advanced prostate cancer.
- Endometriosis: Management of moderate to severe symptoms of endometriosis.
- Uterine Fibroids: Reduction of symptoms associated with uterine fibroids.
- Precocious Puberty: Treatment of children with early onset of puberty (before age 8 in girls and 9 in boys).
Mechanism of Action:
Leuprolide Acetate, when administered continuously, inhibits the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This suppression leads to a decrease in testosterone (in men) and estrogen (in women), resulting in the therapeutic effects, such as reducing tumor size, controlling symptoms of endometriosis, or halting premature puberty.
Dosage and Administration:
- Prostate Cancer: 11.25 mg administered as a single intramuscular injection every 3 months.
- Endometriosis: 3.75 mg monthly or 11.25 mg every 3 months.
- Uterine Fibroids: 3.75 mg monthly or 11.25 mg every 3 months.
- Precocious Puberty: Typically 3.75 mg every month, with the 11.25 mg formulation given every 3 months.
Side Effects:
Common side effects include:
- Hot flashes, sweating, and headache.
- Injection site reactions (pain, redness, swelling).
- Mood changes and depression.
Serious side effects may include:
- Cardiovascular issues: Increased risk of cardiovascular events (especially in men with prostate cancer).
- Bone density loss: Long-term use may reduce bone mineral density.
- Ovarian cysts or gastrointestinal discomfort.
Precautions:
- Bone health: Monitor for osteoporosis in patients on long-term therapy.
- Cardiac risk: Monitor for signs of cardiovascular complications, especially in patients with a history of heart disease.
- Pregnancy: Contraindicated during pregnancy due to potential harm to the fetus.
Storage:
Store at room temperature (20°C–25°C). Protect from light and moisture. Do not freeze.
Conclusion:
11.25mg Leuprolide Acetate Injection is a vital treatment for managing hormone-driven conditions such as prostate cancer, endometriosis, and precocious puberty. Close monitoring of bone health and cardiovascular status is recommended during therapy.
Yes! I am InterestedRequest A Callback
Peracetamol + Lignocaine Injection ( Febrinil L Injection )
Product Price: Rs 40 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 2% w/v |
| Packaging Size | 20ml |
| Packaging Type | Ampoule |
| Injection Administeration Type | IM, IV |
| Usage | As local Anesthetic |
| Prescription/Non-Prescription | Prescription |
| Brand Name | Febrinil L |
| Manufacturer By | Svizera |
Overview: Febrinil L Injection is a combination medication that includes paracetamol (acetaminophen) and lignocaine (lidocaine). This dual-action formulation is used for effective pain relief and fever management, making it particularly useful in clinical settings.
Indications for UseFebrinil L Injection is primarily indicated for:
- Pain Management: Effective for treating moderate to severe pain, especially post-operative or procedural pain.
- Fever Reduction: Paracetamol provides antipyretic effects, helping to lower fever and alleviate discomfort.
- Paracetamol: Acts centrally in the brain to inhibit the synthesis of prostaglandins, resulting in analgesic (pain relief) and antipyretic (fever-reducing) effects.
- Lignocaine: Provides local anesthesia by blocking sodium channels in nerve fibers, interrupting the transmission of pain signals.
- Dosage: The specific dosage will depend on the patient's condition, age, and weight. It should be administered by a healthcare professional.
- Administration Route: Typically given via intravenous injection or infusion.
Common Side Effects:
- Nausea or vomiting
- Dizziness
- Local irritation or discomfort at the injection site
Serious Side Effects:
- Allergic reactions (rare)
- Liver damage with high doses of paracetamol
- Neurological symptoms such as seizures or respiratory depression from lignocaine overdose
- Use with caution in patients with liver impairment or allergies to any components.
- Monitor for signs of toxicity, especially in patients with comorbidities or those on other medications.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be informed to:
- Report any allergies or current medications to their healthcare provider.
- Inform their provider about any unusual symptoms or side effects after administration.
- Understand the importance of follow-up monitoring and care.
Febrinil L Injection effectively combines the analgesic and antipyretic properties of paracetamol with the local anesthetic effects of lignocaine. Proper administration, monitoring, and patient education are essential for achieving the best therapeutic outcomes. Always consult a healthcare professional for specific recommendations regarding its use.
Yes! I am InterestedRequest A Callback
Zoleget 4 Zoledronic Acid Injection
Product Price: Rs 2,500 / PieceGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 4 mg |
| Packaging Size | 1 Injection in 1 vial |
| Manufacturer | Gls Pharma Ltd |
| Composition | Zoledronic Acid 4 mg |
| Brand Name | Zoleget |
| Treatment | Postmenopausal osteoporosis, Pagets disease, Hypercalcemia (high level of calcium) in cancer |
Overview:
Zoleget 4 Injection contains Zoledronic Acid, a bisphosphonate used to treat osteoporosis, Paget's disease of bone, and bone complications associated with certain cancers (e.g., metastatic bone disease or hypercalcemia of malignancy). Zoledronic acid works by inhibiting osteoclast-mediated bone resorption, helping to increase bone density and reduce fracture risk. It also reduces calcium levels in the blood by inhibiting the release of calcium from bones.
Indications:
Zoleget 4 Injection is indicated for:
- Osteoporosis: Treatment and prevention of osteoporosis in postmenopausal women and men at risk for fractures.
- Paget’s disease of bone: Treatment to normalize bone turnover and reduce pain and fractures.
- Bone metastases: Prevention of skeletal-related events in patients with cancer metastasizing to bone (e.g., breast, prostate cancer).
- Hypercalcemia of malignancy: Treatment of high blood calcium levels due to cancer.
Mechanism of Action:
Zoledronic acid inhibits osteoclasts, the cells responsible for bone resorption. It binds to bone surfaces, reducing osteoclast activity and preventing excessive bone breakdown. This leads to increased bone mineral density, decreased fracture risk in osteoporotic patients, and prevention of bone complications in cancer patients. In hypercalcemia of malignancy, it helps lower elevated calcium levels by inhibiting the release of calcium from bone.
Dosage and Administration:
- Osteoporosis: 4 mg intravenously once a year.
- Paget’s disease: 5 mg intravenously once, with the possibility of a second dose after 6 months if necessary.
- Bone metastasis: 4 mg intravenously every 3-4 weeks, depending on the type of cancer and skeletal complications.
- Hypercalcemia of malignancy: 4 mg intravenously once, with adjustments based on calcium levels.
Zoleget 4 is administered as an intravenous infusion over at least 15 minutes. Ensure adequate hydration before infusion to reduce the risk of renal toxicity.
Side Effects:
Common side effects include:
- Fever, fatigue, and muscle or joint pain.
- Headache, nausea, and gastrointestinal discomfort.
Serious side effects may include:
- Osteonecrosis of the jaw: A rare but serious condition, often seen in cancer patients.
- Renal toxicity: Kidney function should be monitored before and after infusion.
- Hypocalcemia: Low calcium levels, particularly after the infusion.
Precautions:
- Renal function: Monitor renal function before and during treatment, especially in patients with pre-existing kidney problems.
- Dental care: Perform dental exams before treatment, as zoledronic acid can increase the risk of osteonecrosis of the jaw.
- Pregnancy and breastfeeding: Zoledronic acid is contraindicated in pregnancy and breastfeeding.
Storage:
Store at room temperature (20°C–25°C). Protect from light. Do not freeze.
Conclusion:
Zoleget 4 (Zoledronic Acid) Injection is an effective treatment for bone-related conditions like osteoporosis, Paget’s disease, and cancer-related bone complications. Regular monitoring of kidney function and calcium levels is essential, along with dental assessments to prevent rare side effects like osteonecrosis of the jaw.
Yes! I am InterestedRequest A Callback
22.5mg Luprova Leuprolide Acetate Depot Injection
Product Price: Rs 99,900 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 22.5 mg |
| Packaging Type | Box |
| Box Contains | Vial And Diluent |
| Form | Injection |
| Brand | Celon Labs |
| Shelf Life | 3 Months |
| Usage | Used To Treat Prostate Cancer |
Yes! I am InterestedRequest A Callback
Polyxx Polymyxin B 500000IU injection
Product Price: Rs 399 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 500000 IU |
| Packaging Type | Vial |
| Pack Type | Bottle |
| Form | Injection |
| Brand Name | Polyxx |
| Manufacturer | Celon Laboratories Ltd |
| Usages | Treatment of Severe bacterial infections |
Overview: Polymyxin B is an antibiotic that belongs to the polymyxin class, primarily used to treat serious infections caused by gram-negative bacteria, particularly multidrug-resistant strains.
Indications:
- Bacterial Infections: Used for the treatment of infections caused by susceptible gram-negative organisms, including:
- Pseudomonas aeruginosa
- Escherichia coli
- Klebsiella pneumoniae
- Topical Infections: May also be used topically for localized infections.
Mechanism of Action: Polymyxin B disrupts the bacterial cell membrane by binding to the lipopolysaccharide component, leading to increased membrane permeability and ultimately causing cell death.
Dosage and Administration:
- Dosage: The typical adult dosage for serious infections may range from 1 to 2 mg/kg/day, divided into multiple doses. Specific dosing can vary based on the severity of the infection and local protocols.
- Administration: Administered intravenously or intramuscularly. Continuous monitoring of kidney function is recommended during treatment.
Contraindications:
- Hypersensitivity to polymyxin B or any component of the formulation.
- Caution in patients with pre-existing kidney issues, as the drug may lead to nephrotoxicity.
Warnings and Precautions:
- Monitor renal function regularly during treatment, as polymyxin B can cause kidney damage.
- Use with caution in patients with respiratory conditions.
Side Effects:
- Common: Nephrotoxicity, neurotoxicity (dizziness, headache), and gastrointestinal disturbances (nausea, vomiting).
- Serious: Risk of severe allergic reactions and respiratory distress.
Drug Interactions:
- May interact with other nephrotoxic medications. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, particularly those related to kidney function or signs of allergic reactions.
Conclusion: Polyxx (Polymyxin B 500,000 IU Injection) is a critical antibiotic for treating serious infections caused by resistant gram-negative bacteria. Proper administration and monitoring are essential to ensure safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Thiosol Thiopentone 1mg Injection
Product Price: Rs 35 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 1gm |
| Packaging Size | 1 Injection in 1 Vial |
| Brand | Thiosol |
| Manufacturer | Neon Laboratories Ltd |
| Composition | Thiopentone 1 gm |
| Treatment | Anesthesia |
Overview: Thiosol is an injectable formulation of thiopental sodium, a rapid-acting barbiturate used primarily as an anesthetic. It is known for its sedative and hypnotic properties, making it suitable for various medical procedures.
Indications for UseThiosol Thiopentone Injection is indicated for:
- Induction of Anesthesia: Used for the rapid induction of general anesthesia in surgical procedures.
- Sedation: Provides sedation for patients undergoing procedures that do not require full anesthesia.
- Control of Seizures: May be used in certain cases of status epilepticus to help control seizures.
Thiopental sodium works by enhancing the inhibitory neurotransmitter effects of gamma-aminobutyric acid (GABA) in the central nervous system. This results in sedation and unconsciousness by depressing the activity of the brain.
Dosage and Administration- Dosage: The dosage varies based on the patient's age, weight, and medical condition. Typical induction doses range from 3 to 5 mg/kg intravenously, but the specific amount should be determined by a healthcare professional.
- Administration Route: Given via slow intravenous injection.
Common Side Effects:
- Drowsiness or dizziness
- Hypotension (low blood pressure)
- Respiratory depression
Serious Side Effects:
- Allergic reactions (rare)
- Cardiovascular instability, especially in high-risk patients
- Use with caution in patients with a history of respiratory issues, cardiovascular problems, or hypersensitivity to barbiturates.
- Monitor vital signs closely during administration and recovery.
- Ensure appropriate resuscitation equipment is available, as thiopental can cause respiratory depression.
- Store at room temperature, protected from light.
- Keep out of reach of children.
Patients should be advised to:
- Inform healthcare providers about any allergies or medical conditions prior to the procedure.
- Discuss any medications they are taking to avoid potential interactions.
- Be aware of post-anesthesia recovery instructions and the need for someone to assist them after the procedure.
Thiosol Thiopentone 1 mg Injection is a vital medication for inducing anesthesia and providing sedation. Proper administration and monitoring are crucial to ensure patient safety and effectiveness during medical procedures. Always consult a healthcare professional for specific guidance regarding its use.
Yes! I am InterestedRequest A Callback
Bupivacaine Injection ( Levo Anawin 0.25 % Injection )
Product Price: Rs 225 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 0.25% |
| Packaging Size | 20ml |
| Composition | Levobupivacaine 0.25% |
| Brand Name | Levo Anawin |
| Manufacturer By | Neon Laboratories Ltd |
| Treatment | Near by Sedation |
Overview:
Bupivacaine, marketed as Levo Anawin, is a long-acting local anesthetic used for regional anesthesia and pain management in various clinical settings.
- Local Anesthesia: Used for surgical procedures requiring local anesthesia, including dental and orthopedic surgeries.
- Epidural Anesthesia: Commonly administered in epidural blocks for pain relief during labor and postoperative analgesia.
- Nerve Blocks: Employed in peripheral nerve blocks for pain management.
Bupivacaine works by blocking sodium channels in the neuronal cell membrane, which inhibits the generation and conduction of nerve impulses. This results in a temporary loss of sensation in the targeted area.
Dosage and Administration- Dosage: The concentration of 0.25% indicates that there are 2.5 mg of bupivacaine per 1 mL of solution. Dosage varies based on the procedure, the area being anesthetized, and patient factors.
- Administration: Administered via local infiltration, nerve block, or epidural injection by a qualified healthcare provider.
Common Side Effects:
- Localized pain or swelling at the injection site
- Nausea
- Dizziness
Serious Side Effects:
- Cardiovascular effects (e.g., hypotension, bradycardia, cardiac arrest)
- Neurological effects (e.g., seizures, prolonged numbness)
- Allergic reactions (e.g., rash, itching)
Patients should be monitored for signs of systemic toxicity, especially if higher doses are used or if injected into a vascular area. Monitoring vital signs during and after administration is essential.
Contraindications- Known hypersensitivity to bupivacaine or other amide-type local anesthetics.
- Use with caution in patients with severe cardiovascular or hepatic conditions.
Inform your healthcare provider about all medications you are taking, especially:
- Other local anesthetics.
- Anticoagulants, which may increase bleeding risk.
Store Levo Anawin at room temperature, protected from light and moisture. Keep out of reach of children.
Patient Counseling Information- Usage: Stress the importance of following administration guidelines and monitoring.
- Side Effects: Discuss potential side effects, particularly those affecting cardiovascular and neurological function.
- Post-Procedure Care: Advise patients to report any unusual symptoms, such as persistent numbness or changes in heart rate.
Levo Anawin (bupivacaine 0.25% injection) is an effective local anesthetic for various procedures. With proper administration and monitoring, it can provide significant pain relief. Always consult a healthcare provider for personalized medical advice and treatment plans.
Yes! I am InterestedRequest A Callback
Propofol Injection (Troypofol 20ml Injection)
Product Price: Rs 85 / VialGet Best Price
Product Brochure
Product Details:
| Packaging Size | 20ml |
| Strength | 1% |
| Brand | Troypofol |
| Manufacturer | Troikaa |
| Country of Origin | Made in India |
| Usage/Application | General Anaesthesia |
Indications: Propofol is primarily indicated for:
- Induction and maintenance of general anesthesia in adults and pediatric patients.
- Sedation for mechanically ventilated patients in an intensive care setting.
- Procedural sedation (e.g., for diagnostic or therapeutic procedures).
Mechanism of Action: Propofol is a short-acting hypnotic agent. It works by enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, leading to sedation and anesthesia.
Dosage and Administration:
- Typical Dosage: The dosage depends on the clinical situation, the patient's age, and other factors. For induction of anesthesia in adults, a common dose is 1-2.5 mg/kg administered intravenously. For maintenance, it can be given as a continuous infusion or intermittent boluses.
- Administration: Propofol should be administered by a qualified healthcare professional in a setting equipped for anesthesia.
Side Effects:
- Common: Hypotension, respiratory depression, injection site pain, and dizziness.
- Serious: Anaphylaxis, propofol-related infusion syndrome (PRIS), and severe respiratory depression.
Contraindications:
- Hypersensitivity to propofol or any component of the formulation.
- Caution in patients with a history of egg or soy allergies, as the formulation may contain these ingredients.
Warnings and Precautions:
- Cardiovascular Effects: Monitor blood pressure and heart rate closely, as propofol can cause hypotension.
- Respiratory Depression: Be prepared for airway management and monitoring of respiratory function during and after administration.
- PRIS: This syndrome, characterized by metabolic acidosis, cardiac failure, and rhabdomyolysis, can occur with prolonged infusions of propofol.
Drug Interactions: Propofol may interact with other CNS depressants, leading to enhanced sedation and respiratory depression. Always inform healthcare providers of all medications being taken.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Once opened, the product should be used immediately or stored according to guidelines.
Patient Counseling Information:
- Explain the purpose of the medication and what to expect during the procedure.
- Discuss potential side effects and the need for monitoring during and after administration.
- Advise patients about the importance of reporting any unusual symptoms post-procedure.
Propofol Injection (Troypofol 20 mL) is a widely used anesthetic agent with specific indications for various medical procedures. It should be administered by trained professionals in a controlled environment. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
440mg Trumab Trastuzumab Injections
Product Price: Rs 45,000 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 440 mg |
| Pack Size | 20 ml in 1 vial |
| Composition | Trastuzumab (440mg) |
| Brand | Hermab |
| Manufacturer | RPG Life Sciences Ltd |
| Treatment | Breast Cancer and Stomach Cancer |
Overview: 440mg Trastuzumab Injection contains Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer and HER2-positive gastric cancer. Trastuzumab works by targeting and binding to the HER2 receptor on cancer cells, inhibiting tumor growth and promoting the immune system's ability to destroy the cancer cells.
Indications: Trastuzumab 440mg Injection is indicated for:
- HER2-positive Breast Cancer: Treatment of early breast cancer (after surgery) and metastatic breast cancer.
- HER2-positive Gastric Cancer: Treatment of advanced or metastatic gastric cancer with HER2 overexpression.
Mechanism of Action: Trastuzumab binds to the HER2 receptor, which is overexpressed in certain types of cancer cells. By blocking HER2 signaling, Trastuzumab inhibits cell growth and induces antibody-dependent cellular cytotoxicity (ADCC), where immune cells destroy cancer cells. This action slows tumor progression and can shrink existing tumors.
Dosage and Administration:
- Breast Cancer:
- Initial dose: 8mg/kg (loading dose) intravenously, followed by 6mg/kg every 3 weeks.
- Gastric Cancer:
- Initial dose: 8mg/kg intravenously, followed by 6mg/kg every 3 weeks.
The 440mg vial is typically used for patients weighing between 73.3kg to 110kg, but the dose is based on the patient's weight and HER2-positive tumor status.
Side Effects: Common side effects include:
- Fever, nausea, fatigue, and headache.
- Cardiotoxicity: Heart failure, particularly in patients with preexisting heart conditions.
- Infusion-related reactions: Fever, chills, nausea, and fatigue.
- Diarrhea and rash.
Serious side effects may include:
- Severe cardiac events (e.g., heart failure), lung toxicity, and allergic reactions.
Precautions:
- Cardiac function: Monitor heart function, especially in patients with prior heart disease.
- Infusion reactions: Premedication may be needed to prevent reactions.
- Pregnancy: Trastuzumab is contraindicated during pregnancy due to fetal harm.
Storage: Store the vial at 2°C to 8°C. Do not freeze. Keep out of reach of children.
Conclusion: 440mg Trastuzumab Injection is an effective treatment for HER2-positive breast and gastric cancer, blocking tumor growth and enhancing immune response. Careful monitoring for heart function and infusion reactions is necessary.
Yes! I am InterestedRequest A Callback
Anidulafungin Injection (Canidula 100mg Injection )
Product Price: Rs 6,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Packaging Size | 1 Injection in 1 vial |
| Composition | Anidulafungin 100mg |
| Brand | Canidula |
| Manufacturer | Anidulafungin 100mg |
| Usage/Application | Severe Fungal Infections |
Overview: Anidulafungin is an echinocandin antifungal agent used to treat certain serious fungal infections. It is particularly effective against Candida and Aspergillus species.
Uses:- Candidemia: Treatment of invasive candidiasis, including candidemia (fungal infection in the bloodstream).
- Esophageal Candidiasis: Used in the treatment of esophageal candidiasis in patients who are unable to take oral antifungal medications.
- Other Fungal Infections: May be used for other invasive fungal infections based on clinical judgment.
- Typical Dose: The initial dose is usually 200 mg on the first day, followed by 100 mg daily for subsequent doses. Treatment duration varies depending on the type and severity of the infection.
- Administration: Administered intravenously. The infusion should be given slowly over at least 1.5 hours.
Anidulafungin works by:
- Inhibiting the synthesis of β-(1,3)-D-glucan, an essential component of the fungal cell wall, leading to cell lysis and death of the fungus.
- Common: Nausea, vomiting, headache, and infusion site reactions (such as pain or redness).
- Serious: Liver enzyme elevation, allergic reactions, and anaphylaxis. Seek immediate medical attention for severe reactions.
- Liver Function: Monitor liver function tests, as anidulafungin may cause liver enzyme elevations.
- Infusion Reactions: Be aware of potential infusion-related reactions; administer the infusion slowly.
- Pregnancy and Breastfeeding: Discuss the risks and benefits with your healthcare provider if you are pregnant or breastfeeding.
- Known hypersensitivity to anidulafungin or any components of the formulation.
- Anidulafungin has a low potential for drug interactions, but always inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements.
- Store at room temperature. After reconstitution, it should be used promptly or stored in the refrigerator for a short time. Keep out of reach of children.
- Follow the prescribed treatment regimen and complete the full course, even if symptoms improve.
- Report any unusual side effects or symptoms to your healthcare provider promptly.
- Inform healthcare providers about your history of allergies or any other medical conditions.
Canidula (Anidulafungin 100 mg Injection) is an effective treatment for serious fungal infections. Proper administration, monitoring, and patient education are essential for optimal outcomes. Always consult your healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Tigez Tigecycline 50mg Injection
Product Price: Rs 1,698 / VialGet Best Price
Product Brochure
Product Details:
| Dose Strengthc | 50 mg, 50 mg |
| Manufactured By | Lupin |
| Usage/Application | Personal |
| Brand Name | Tigez |
| Treatment | Severe Bacterial Infections |
| Prescription/Non prescription | Non prescription |
| Composition | Tigecycline 50mg |
Overview: Tigecycline is a broad-spectrum glycylcycline antibiotic used for treating a variety of complicated infections. It is particularly effective against multidrug-resistant bacteria.
Indications:
- Complicated Skin and Skin Structure Infections: Effective for treating infections caused by susceptible gram-positive and gram-negative bacteria.
- Complicated Intra-Abdominal Infections: Used in treating infections involving the abdominal cavity.
- Community-Acquired Pneumonia: Indicated for the treatment of pneumonia caused by resistant organisms.
Mechanism of Action: Tigecycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the incorporation of amino acids into proteins. This action is effective against a wide range of bacteria, including resistant strains.
Dosage and Administration:
- Dosage: The typical initial dose is 100 mg, followed by 50 mg every 12 hours. Duration of therapy depends on the severity and type of infection.
- Administration: Given intravenously. The infusion should be done slowly over approximately 30 to 60 minutes.
Contraindications:
- Hypersensitivity to tigecycline or any component of the formulation.
- Caution in patients with a history of allergies to tetracycline-class antibiotics.
Warnings and Precautions:
- Monitor for signs of hepatotoxicity; liver function tests should be performed periodically.
- Use with caution in patients with renal impairment; dosage adjustments may be necessary.
Side Effects:
- Common: Nausea, vomiting, diarrhea, and infusion site reactions.
- Serious: Risk of hepatotoxicity, pancreatitis, and severe allergic reactions.
Drug Interactions:
- May interact with other medications, particularly those affecting liver enzymes. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, especially gastrointestinal issues or signs of liver dysfunction.
Conclusion: Tigez (Tigecycline 50 mg Injection) is an important antibiotic for treating complex infections caused by resistant bacteria. Proper administration and monitoring are essential for ensuring safety and efficacy. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Cetuxa Cetuximab 100 Mg/20 Ml Injection
Product Price: Rs 7,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Dose/Strength | 100 mg/20 ml |
| Packaging Type | 1 Vial(s) Of 20ml |
| Composition | Cetuximab 100 mg/20 ml |
| Brand Name | Cetuxa |
| Manufacturer | Alkem Laboratories Ltd |
| Treatment | Cancer |
Overview:
20ml Cetuxa (Cetuximab) Injection contains Cetuximab, a monoclonal antibody used in the treatment of certain head and neck cancers and colorectal cancer. Cetuximab targets the epidermal growth factor receptor (EGFR) on cancer cells, inhibiting the signaling pathways that promote tumor growth. It is typically used in combination with other chemotherapy agents or as a single-agent treatment.
Indications:
20ml Cetuxa (Cetuximab) Injection is indicated for:
- Metastatic Colorectal Cancer (CRC): In combination with chemotherapy for patients whose tumors express EGFR.
- Head and Neck Squamous Cell Carcinoma (HNSCC): For locally advanced or metastatic cases, often in combination with radiation or chemotherapy.
- Non-Small Cell Lung Cancer (NSCLC): In combination with chemotherapy for specific EGFR-expressing tumors.
Mechanism of Action:
Cetuximab binds to the EGFR on cancer cells, blocking the activation of downstream signaling pathways that drive cell division, survival, and tumor progression. By inhibiting EGFR, Cetuximab prevents the growth of tumors and enhances immune system recognition and destruction of cancer cells.
Dosage and Administration:
- Metastatic Colorectal Cancer: Initial dose of 400 mg/m² intravenously, followed by 250 mg/m² weekly.
- Head and Neck Cancer: Initial dose of 400 mg/m² intravenously, followed by 250 mg/m² weekly.
- Non-Small Cell Lung Cancer: Dose varies based on the treatment regimen.
Cetuximab is typically administered intravenously, with infusion rates adjusted based on patient tolerance.
Side Effects:
Common side effects include:
- Infusion reactions (fever, chills, nausea, rash).
- Skin reactions (acneiform rash, dry skin).
- Fatigue, diarrhea, and loss of appetite.
Serious side effects may include:
- Severe allergic reactions (anaphylaxis).
- Lung toxicity, including interstitial lung disease.
- Electrolyte disturbances, such as low magnesium and calcium levels.
Precautions:
- Infusion reactions: Monitor patients during and after infusion, especially during the first dose.
- Cardiopulmonary monitoring: Cetuximab may cause severe reactions, requiring appropriate medical intervention.
- Pregnancy: Cetuximab is contraindicated during pregnancy due to potential harm to the fetus.
Storage:
Store at 2°C to 8°C. Do not freeze. Protect from light.
Conclusion:
20ml Cetuxa (Cetuximab) Injection is a targeted therapy for treating colorectal, head and neck, and certain lung cancers. It works by inhibiting EGFR, blocking tumor growth. Regular monitoring for infusion reactions and skin issues is recommended.
Yes! I am InterestedRequest A Callback
440mg TrastuRel Injection
Product Price: Rs 42,500 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 440 mg |
| Packaging Type | Vial |
| Brand Name | Trastuzumab |
| Manufactured By | Reliance Life Sciences |
| Usage | Hospital |
Trasturel 440 mg Injection
Overview:
Trasturel (Trastuzumab) is a monoclonal antibody used primarily for the treatment of HER2-positive breast cancer and metastatic gastric cancer. By targeting the HER2 (human epidermal growth factor receptor 2) protein, which is overexpressed in certain types of cancer, Trasturel inhibits the growth of cancer cells. Trasturel is used alone or in combination with other chemotherapy drugs to improve the chances of tumor shrinkage and disease progression.
Indications:
Trasturel 440 mg Injection is indicated for:
- Breast Cancer: HER2-positive breast cancer in early-stage, adjuvant therapy, or metastatic disease.
- Gastric Cancer: HER2-positive metastatic gastric cancer or gastroesophageal junction cancer.
- Other Cancers: May be used in combination with other agents for various cancers expressing HER2.
Mechanism of Action:
Trasturel binds to the HER2 protein, preventing its activation and subsequent signaling that leads to uncontrolled cell growth. This blockage reduces tumor growth and may induce immune-mediated cell death. Trasturel also enhances the effectiveness of chemotherapy by targeting cancer cells for destruction by the immune system.
Dosage and Administration:
- Recommended Dose: For breast cancer, the initial dose is 8 mg/kg as a loading dose, followed by 6 mg/kg every three weeks. For gastric cancer, the typical dose is 8 mg/kg initially, followed by 6 mg/kg every three weeks.
- Administration: Administered by intravenous infusion over 90 minutes initially, followed by 30 minutes for subsequent doses. Healthcare providers should monitor for infusion reactions.
Side Effects:
Common side effects include:
- Fever, chills, and nausea.
- Fatigue and headache.
- Diarrhea and rash. Serious side effects may include:
- Cardiotoxicity: Risk of heart failure, particularly with prolonged use.
- Infusion reactions: Fever, chills, difficulty breathing, and hypotension.
- Pulmonary toxicity: Shortness of breath and cough.
Precautions:
- Cardiac function: Monitor heart function, especially in patients with pre-existing heart conditions.
- Pregnancy: Contraindicated during pregnancy as it can cause fetal harm.
- Infusion Reactions: Monitor patients for signs of infusion-related reactions.
Storage:
Store Trasturel 440 mg Injection in the refrigerator (2°C to 8°C). Do not freeze. Protect from light.
Conclusion:
Trasturel 440 mg Injection is an effective targeted therapy for HER2-positive cancers, particularly breast and gastric cancers. Regular monitoring for heart function and infusion reactions is necessary for patient safety.
Yes! I am InterestedRequest A Callback
Bupivacaine Injection ( Bupifix-P Injection )
Product Price: Rs 450 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 0.5% |
| Packaging Size | 20ml |
| Composition | Bupivacaine 5 mg |
| Brand Name | Bupifix-P |
| Manufacturer By | Varenyam Healthcare Pvt Ltd |
| Treatment | Local anesthesia |
Overview: Bupifix-P is an injectable formulation of bupivacaine, a long-acting local anesthetic used for various medical and surgical procedures. It provides effective pain relief by blocking nerve signals in the targeted area.
Indications for UseBupifix-P Injection is primarily indicated for:
- Local Anesthesia: Used for surgical procedures, including orthopedic, dental, and obstetric surgeries.
- Regional Anesthesia: Employed in nerve blocks, epidural anesthesia, and peripheral nerve blocks for pain management during and after surgery.
- Labor Analgesia: Provides pain relief during labor and delivery.
Bupivacaine works by blocking sodium channels in nerve membranes, inhibiting the transmission of pain signals. This results in localized numbness and pain relief in the affected area.
Dosage and Administration- Dosage: The specific dosage depends on the procedure, the area being anesthetized, and the patient's individual response. Typical doses can range from 5 to 15 mg for local infiltration and higher for regional blocks.
- Administration Route: Administered via local injection or regional techniques such as epidural or nerve block.
Common Side Effects:
- Localized numbness or tingling
- Temporary weakness in the injected area
- Pain at the injection site
Serious Side Effects:
- Allergic reactions (rare)
- Systemic toxicity: Symptoms may include dizziness, tinnitus, seizures, or cardiovascular issues if absorbed into the bloodstream.
- Use with caution in patients with known allergies to local anesthetics or those with cardiovascular or neurological disorders.
- Monitor for signs of systemic toxicity, especially in cases of higher doses or accidental intravascular injection.
- Ensure resuscitation equipment is available when administering bupivacaine, particularly for regional anesthesia.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be advised to:
- Inform healthcare providers about any allergies or previous reactions to anesthetics.
- Discuss any medical conditions or medications prior to the procedure.
- Understand the potential for temporary numbness or weakness after administration and the need for assistance if necessary.
Bupivacaine Injection (Bupifix-P) is an effective local anesthetic used for pain management in various medical settings. Proper administration, monitoring, and patient education are crucial for ensuring safety and effectiveness during procedures. Always consult a healthcare professional for specific guidance regarding its use.
Yes! I am InterestedRequest A Callback
Streptomycin Injection(Ambistryn-S 0.75gm Injection)
Product Price: Rs 85 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 0.75gm |
| Form | Injection |
| Packaging Type | Vial |
| Brand | Ambistryn-S |
| Manufacturer | Abbott |
| Composition | Streptomycin 0.75gm |
| Usage | Tuberculosis (TB) |
Indications: Ambistryn-S (streptomycin) is primarily indicated for:
- Treatment of tuberculosis (TB) as part of a multi-drug regimen.
- Treatment of infections caused by certain susceptible bacteria, including those responsible for plague and tularemia.
- May also be used for other serious infections caused by gram-negative bacteria.
Mechanism of Action: Streptomycin is an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of bacteria, leading to the misreading of mRNA and ultimately preventing bacterial growth and replication.
Dosage and Administration:
- Typical Dosage: The dosage depends on the type and severity of the infection. For tuberculosis, the usual adult dose is 15 mg/kg (up to 1 gm) intramuscularly once daily.
- Administration: Administered as an intramuscular injection by a healthcare professional. Ensure proper technique to avoid tissue damage.
Side Effects:
- Common: Nausea, vomiting, diarrhea, rash, and dizziness.
- Serious: Nephrotoxicity (kidney damage), ototoxicity (hearing loss), and allergic reactions.
Contraindications:
- Hypersensitivity to streptomycin or any component of the formulation.
- History of significant renal impairment or hearing loss.
Warnings and Precautions:
- Monitoring: Regular monitoring of renal function and hearing is recommended during treatment, especially in patients with pre-existing conditions.
- Pregnancy: Use with caution in pregnant women, as it may cause fetal harm.
Drug Interactions: Streptomycin may interact with other nephrotoxic or ototoxic medications. Inform healthcare providers about all medications being taken, including over-the-counter drugs.
Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Avoid freezing.
Patient Counseling Information:
- Advise patients on the importance of completing the full course of therapy, even if symptoms improve.
- Discuss potential side effects, especially those related to kidney function and hearing.
- Encourage patients to report any unusual symptoms, particularly changes in hearing or signs of kidney issues.
Ambistryn-S (Streptomycin Injection 0.75 gm) is an effective antibiotic for treating specific bacterial infections, including tuberculosis. Patients should be well-informed about its use, potential side effects, and the importance of adherence to the treatment regimen. Always consult a healthcare provider for personalized medical advice.
Yes! I am InterestedRequest A Callback
Bortenat Bortezomib 3.5 Mg Injection
Product Price: Rs 2,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 3.5 mg |
| Packaging Type | Vial |
| Composition | Bortezomib 3.5 mg/ml |
| Packaging Size | 3.5 mg/ml in 1 Vial |
| Brand | Bortenat |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Multiple Myeloma |
Bortenat Bortezomib 3.5 mg Injection is a potent proteasome inhibitor used primarily in the treatment of multiple myeloma and certain types of lymphoma. By disrupting the proteasome function, Bortezomib helps to induce apoptosis (programmed cell death) in cancer cells, leading to improved treatment outcomes.
What is Bortezomib?Bortezomib is a synthetic peptide that selectively inhibits the 26S proteasome, a complex responsible for degrading ubiquitinated proteins. This inhibition leads to the accumulation of regulatory proteins that promote apoptosis and cell cycle arrest in malignant cells.
IndicationsBortenat is indicated for:
- Multiple Myeloma: Used in combination with other therapies for newly diagnosed or relapsed disease.
- Mantle Cell Lymphoma: Effective in patients who have received at least one prior therapy.
Bortezomib works by:
- Inhibiting Proteasome Activity: This leads to the accumulation of pro-apoptotic factors and the downregulation of anti-apoptotic factors, facilitating cancer cell death.
- Modulating Signaling Pathways: It alters various signaling pathways involved in cell growth and survival, enhancing the efficacy of other anticancer agents.
- Dosage: The typical dose of Bortenat is 3.5 mg, administered via intravenous injection or subcutaneously.
- Administration Schedule: Often given on a specific schedule, such as twice a week for two weeks, followed by a rest period. The exact regimen depends on the patient's condition and response to treatment.
Bortenat is contraindicated in:
- Hypersensitivity: Known allergy to bortezomib or any components of the formulation.
- Severe Thrombocytopenia: Patients with significantly low platelet counts should not receive this therapy.
- Monitor Blood Counts: Regular monitoring of blood cell counts is essential due to the risk of thrombocytopenia and neutropenia.
- Heart Health: Caution is advised in patients with a history of heart problems, as bortezomib may increase the risk of heart failure.
Common side effects may include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Peripheral neuropathy (tingling or numbness in hands and feet)
Serious side effects can include:
- Severe allergic reactions (anaphylaxis)
- Cardiac complications
- Infections due to immune suppression
Bortenat may interact with other medications. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.
Storage InstructionsStore Bortenat Bortezomib 3.5 mg Injection at room temperature, away from light and moisture. Follow specific guidelines for use after opening.
Patient Counseling Information- Explain the purpose and administration of Bortenat.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Emphasize the need for regular follow-up appointments to monitor treatment effectiveness and manage side effects.
Bortenat Bortezomib 3.5 mg Injection is an essential treatment option for patients with multiple myeloma and certain lymphomas, providing targeted therapy that enhances the effectiveness of treatment regimens. Always consult a healthcare provider for personalized medical advice tailored to individual treatment needs.
Yes! I am InterestedRequest A Callback
Palonosetron Hydrochloride 250 mcg / 5 ml Injection (Themiset 250 mcg / 5 ml Injection)
Product Price: Rs 450 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 25 mcg |
| Pack Size | 5 ml |
| Brand Name | Themiset |
| Manufacturer | Themis Medicare Ltd |
| Treatment | Nausea |
Palonosetron Hydrochloride Injection (Themiset 250 mcg / 5 ml)
Indications:
Palonosetron is indicated for the prevention of nausea and vomiting associated with highly emetogenic chemotherapy, as well as for the prevention of postoperative nausea and vomiting.
Mechanism of Action:
Palonosetron is a selective 5-HT3 receptor antagonist. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting, particularly in response to chemotherapy or surgical procedures.
Dosage and Administration:
- Dosage: The recommended dose of palonosetron is 0.25 mg (250 mcg) administered as a single intravenous dose approximately 30 minutes before the start of chemotherapy or surgery.
- Administration: Administer via slow intravenous injection or infusion over 30 seconds to 15 minutes. Do not dilute or mix with other medications.
Contraindications:
- Hypersensitivity to palonosetron or any component of the formulation.
Warnings and Precautions:
- Cardiac Effects: Use caution in patients with a history of cardiac arrhythmias or electrolyte abnormalities.
- Serotonin Syndrome: Monitor for symptoms of serotonin syndrome, especially if used in conjunction with other serotonergic agents.
Side Effects:
Common side effects may include:
- Headache
- Dizziness
- Fatigue
- Constipation
Serious side effects can include:
- Severe allergic reactions
- Cardiac arrhythmias
- Serotonin syndrome
Drug Interactions:
Palonosetron may interact with other medications that affect serotonin levels or have cardiotoxic potential. Patients should inform their healthcare provider about all medications they are taking.
Storage:
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze.
Patient Counseling Information:
- Advise patients to report any severe headaches, dizziness, or unusual symptoms following administration.
- Discuss the importance of adhering to the prescribed treatment schedule, especially when undergoing chemotherapy or surgery.
- Inform patients about potential side effects and when to seek medical attention.
Conclusion:
Palonosetron is an effective antiemetic for preventing nausea and vomiting related to chemotherapy and surgery. Ongoing communication with healthcare providers is essential for managing potential side effects and ensuring optimal treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Pemetrexed 100 Mg Injection (Pemetero 100 Mg Injection)
Product Price: Rs 1,200 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Pack Type | Vial |
| Brand Name | Pemetero |
| Manufacturer | Hetero Drugs Ltd |
| Packaging Size | 1 Injection in 1 Vial |
Pemetrexed Injection (Pemetero 100 mg)
Indications:
Pemetrexed is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. It is often used in combination with other chemotherapy agents.
Mechanism of Action:
Pemetrexed is an antifolate that inhibits multiple enzymes involved in purine and pyrimidine synthesis, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. This inhibition disrupts DNA and RNA synthesis, leading to cancer cell death.
Dosage and Administration:
- Dosage: The typical recommended dose of pemetrexed for NSCLC is 100 mg/m² administered intravenously. Dosing may vary based on the specific treatment regimen and patient tolerance.
- Administration: Administer via intravenous infusion over 10 minutes. Proper hydration is recommended prior to administration, and premedication with folic acid and vitamin B12 may be used to reduce toxicity.
Contraindications:
- Hypersensitivity to pemetrexed or any component of the formulation.
- History of severe hypersensitivity reactions to other antifolate agents.
Warnings and Precautions:
- Bone Marrow Suppression: Monitor blood counts regularly, as pemetrexed can cause leukopenia, thrombocytopenia, and anemia.
- Renal Impairment: Use with caution in patients with renal dysfunction; dosage adjustments may be necessary based on creatinine clearance.
- Gastrointestinal Toxicity: Be vigilant for signs of gastrointestinal toxicity, such as diarrhea or mucositis.
Side Effects:
Common side effects may include:
- Nausea
- Vomiting
- Fatigue
- Rash
- Anorexia
Serious side effects can include:
- Severe allergic reactions
- Bone marrow suppression
- Renal impairment
Drug Interactions:
Pemetrexed may interact with other medications that affect renal function or hematologic parameters. Patients should inform their healthcare provider about all medications they are taking.
Storage:
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:
- Advise patients to report any signs of infection, unusual bruising or bleeding, or gastrointestinal symptoms.
- Emphasize the importance of adhering to the treatment schedule and attending regular follow-up appointments for blood count monitoring.
- Encourage patients to maintain adequate hydration and a balanced diet during treatment.
Conclusion:
Pemetrexed is a valuable treatment option for non-small cell lung cancer and malignant pleural mesothelioma. Ongoing communication with healthcare providers is crucial for managing potential side effects and optimizing treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
2mg Bortezomib Injection
Product Price: Rs 1,250 / VialGet Best Price
Product Brochure
Product Details:
| Dose/Strength | 2 mg |
| Brand | Bortenat |
| Storage Condition | Store below 25 DegreeC |
| Manufactured By | Natco Pharma Ltd |
| Treatment | Multiple Myeloma |
Bortezomib 2 mg Injection (Bortenat 2 mg Injection)
Indications:
Bortezomib is indicated for the treatment of multiple myeloma and certain types of lymphoma, specifically in patients who have received at least one prior therapy.
Mechanism of Action:
Bortezomib is a proteasome inhibitor that disrupts the proteasome's function, leading to the accumulation of regulatory proteins that promote apoptosis (programmed cell death) in cancer cells. This mechanism helps to inhibit tumor growth and induce cell death.
Dosage and Administration:
- Dosage: The recommended dose of Bortezomib is typically 1.3 mg/m² administered intravenously or subcutaneously on days 1, 4, 8, and 11 of a 21-day treatment cycle. Dosage may vary based on the specific condition and patient response.
- Administration: Administer via intravenous infusion or subcutaneous injection. Rotate injection sites to minimize discomfort.
Contraindications:
- Hypersensitivity to bortezomib or any component of the formulation.
- Caution is advised in patients with a history of neuropathy.
Warnings and Precautions:
- Neuropathy: Monitor for symptoms of peripheral neuropathy and adjust dosing as necessary.
- Infections: Increased risk of infections; monitor patients closely for signs of infection.
- Blood Disorders: Regularly assess blood counts, as bortezomib can cause thrombocytopenia and neutropenia.
Side Effects:
Common side effects may include:
- Nausea
- Fatigue
- Diarrhea
- Peripheral neuropathy
- Thrombocytopenia
Serious side effects can include:
- Severe allergic reactions
- Cardiac issues, including congestive heart failure
- Infections
Drug Interactions:
Bortezomib may interact with other medications, particularly those that affect blood clotting or immune function. Patients should inform their healthcare provider of all medications they are taking.
Storage:
Store at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
Patient Counseling Information:
- Advise patients to report any signs of infection, unusual bruising or bleeding, or symptoms of neuropathy.
- Discuss the importance of adhering to the treatment schedule and regular follow-up appointments.
- Encourage patients to maintain a healthy lifestyle, including proper nutrition and hydration, to support overall health during treatment.
Conclusion:
Bortezomib is an effective treatment option for multiple myeloma and certain lymphomas, helping to improve patient outcomes through its targeted mechanism of action. Ongoing communication with healthcare providers is essential for managing side effects and optimizing therapy. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Adrenaline Bitartrate ( Vasocon) Injection
Product Price: Rs 10 / PieceGet Best Price
Product Brochure
Product Details:
| Packaging Size | 10X5X1 ml Amp |
| Stremgth | 1 mg/ml |
| Composition | Adrenaline 1 mg |
| Brand Name | Vasocon |
| Manufacturer By | Neon Laboratories Ltd |
| Usage | Treatment of Cardiac arrest |
Overview: Vasocon is an injectable formulation of adrenaline bitartrate (epinephrine), a potent sympathomimetic agent that stimulates alpha and beta-adrenergic receptors. It is primarily used in emergency situations for its rapid onset of action in various clinical scenarios.
Indications for UseVasocon Injection is indicated for:
- Anaphylaxis: Treatment of severe allergic reactions that can cause difficulty breathing and shock.
- Cardiac Arrest: Used during cardiopulmonary resuscitation (CPR) to improve the chances of return of spontaneous circulation.
- Asthma Attacks: Effective in managing acute severe asthma exacerbations by dilating airways.
- Local Anesthesia: As a vasoconstrictor to prolong the effects of local anesthetics.
Adrenaline acts on both alpha and beta-adrenergic receptors:
- Alpha-adrenergic stimulation: Causes vasoconstriction, leading to increased blood pressure.
- Beta-1 adrenergic stimulation: Increases heart rate and myocardial contractility.
- Beta-2 adrenergic stimulation: Causes bronchodilation, improving airflow in the lungs.
- Dosage: The specific dosage depends on the indication. For anaphylaxis, adult doses typically range from 0.3 to 0.5 mg (0.3 to 0.5 mL of a 1:1000 solution) administered intramuscularly. For cardiac arrest, 1 mg (10 mL of a 1:10,000 solution) is given intravenously during CPR.
- Administration Route: Can be given intramuscularly, intravenously, or subcutaneously, depending on the clinical scenario.
Common Side Effects:
- Increased heart rate (tachycardia)
- Palpitations
- Anxiety or restlessness
Serious Side Effects:
- Hypertension (high blood pressure)
- Arrhythmias (irregular heartbeats)
- Severe allergic reactions (anaphylaxis, though rare with proper dosing)
- Use with caution in patients with cardiovascular disease, hypertension, or hyperthyroidism.
- Monitor patients closely for adverse reactions, especially after the initial dose.
- Always ensure proper dosage to avoid overdose, which can lead to significant cardiovascular effects.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be advised to:
- Understand the importance of carrying an emergency kit if they have known severe allergies.
- Inform healthcare providers about any existing medical conditions or medications they are taking.
- Recognize the signs of anaphylaxis and know how to use an auto-injector if prescribed.
Adrenaline Bitartrate (Vasocon) Injection is a critical medication for managing life-threatening conditions such as anaphylaxis and cardiac arrest. Proper administration and monitoring are essential to ensure patient safety and efficacy. Always consult a healthcare professional for specific guidance regarding its use.
Yes! I am InterestedRequest A Callback
Azatirel 100 mg Azacitidine Injection
Product Price: Rs 4,265 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Packaging Size | 1 Powder for Injection in 1 Vial |
| Brand | AzatiRel |
| Manufacturer | Reliance Life Sciences |
| Treatment | Blood cancer and Myelodysplastic syndrome |
Yes! I am InterestedRequest A Callback
Lidocaine (2%) + Adrenaline (0.005MG) Lox 2% Adrenaline Injection
Product Price: Rs 20 / VialGet Best Price
Product Brochure
Product Details:
| Packaging Size | 30ml |
| Dose/Strength | Lidocaine 2%, Adrenaline 0.005mg |
| Pack Size | 30 ml Injection in 1 Vial |
| Composition (salt) | Lidocaine (2%) + Adrenaline (0.005mg) |
| Brand Name | Lox |
| Manufacturer By | Neon Laboratories Ltd |
| Treatment | Local anesthesia (Numb tissues in a specific area) |
Overview: Lox 2% Adrenaline Injection is a combination of lidocaine, a local anesthetic, and adrenaline (epinephrine), a vasoconstrictor. This formulation is used to provide effective pain relief while minimizing bleeding during surgical procedures.
Indications for UseLox 2% Adrenaline Injection is primarily indicated for:
- Local Anesthesia: Provides anesthesia for minor surgical procedures, dental work, and diagnostic tests.
- Hemostasis: The addition of adrenaline helps reduce bleeding in the surgical area by constricting blood vessels.
- Lidocaine (2%): Blocks sodium channels in nerve membranes, inhibiting nerve impulse transmission, which results in localized numbness.
- Adrenaline (0.005 mg): Causes vasoconstriction, reducing blood flow to the area, which prolongs the anesthetic effect and minimizes bleeding during procedures.
- Dosage: The specific dosage depends on the procedure and patient factors. Typical administration involves injecting a small volume into the affected area.
- Administration Route: Usually given via local injection; the total volume and concentration may vary based on the clinical situation.
Common Side Effects:
- Localized swelling or redness at the injection site
- Nausea or dizziness
Serious Side Effects:
- Allergic reactions (rare)
- Systemic toxicity from lidocaine (e.g., seizures, cardiovascular issues) if absorbed in significant amounts.
- Increased heart rate or blood pressure from adrenaline, especially in sensitive patients.
- Use with caution in patients with known allergies to local anesthetics or adrenaline.
- Monitor patients for signs of toxicity, particularly with higher doses or sensitive populations.
- Avoid use in areas with compromised blood flow.
- Store at room temperature, away from light and moisture.
- Keep out of reach of children.
Patients should be advised to:
- Inform healthcare providers about any known allergies or medications they are taking.
- Report any unusual symptoms or side effects, particularly signs of systemic reactions like increased heart rate or allergic responses.
- Understand the importance of follow-up care and monitoring after the procedure.
Lidocaine (2%) + Adrenaline (0.005 mg) (Lox 2% Adrenaline Injection) is an effective local anesthetic for various medical applications, particularly when hemostasis is needed. Proper administration, monitoring, and patient education are crucial for maximizing therapeutic benefits while minimizing risks. Always consult a healthcare professional for specific guidance regarding its use.
Yes! I am InterestedRequest A Callback
10mg Cladrim Cladribine Injection
Product Price: Rs 12,000 / VialGet Best Price
Minimum Order Quantity: 10 Vial
Product Brochure
Product Details:
| Strength | 10 mg / 10 ml |
| Packaging Type | Vial |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Uses | Hairy cell leukemia |
| Brand | Cladrim |
Overview: 10mg Cladrim contains Cladribine, a purine nucleoside analogue used as an anticancer and immunosuppressive agent. It is primarily indicated for the treatment of Hairy Cell Leukemia (HCL) and is also used for multiple sclerosis (MS) in some cases. Cladribine works by interfering with DNA synthesis and repair, leading to cell death, particularly in rapidly dividing cancer cells and immune cells.
Indications: Cladrim 10mg Injection is indicated for:
- Hairy Cell Leukemia (HCL): Treatment of adult patients with HCL.
- Multiple Sclerosis (MS): In certain cases, as a second-line therapy to reduce relapses and slow disease progression.
Mechanism of Action: Cladribine is metabolized inside the cell into its active form, which incorporates into DNA during replication. It inhibits the activity of DNA polymerase, leading to DNA strand breaks and ultimately cell death. The drug selectively targets lymphocytes, especially those involved in HCL and MS, making it effective in reducing abnormal immune responses.
Dosage and Administration:
- Hairy Cell Leukemia (HCL): Administered as an intravenous infusion of 0.1 to 0.14 mg/kg daily for 5 days (one treatment cycle), typically repeated after 4-8 weeks.
- Multiple Sclerosis: Administered as 1 mg/kg for 4 consecutive days per year in 2 cycles (administered on 2 separate years).
The dose is based on the patient's weight and medical condition. The drug is typically given under the supervision of a healthcare professional, as it is administered intravenously.
Side Effects: Common side effects include:
- Fatigue, fever, and headache.
- Gastrointestinal symptoms: Nausea, vomiting, abdominal pain.
- Bone marrow suppression: Neutropenia, thrombocytopenia, and anemia.
- Infections: Increased risk of opportunistic infections due to immune suppression.
Serious side effects may include:
- Severe infections, liver toxicity, and tumor lysis syndrome.
- Neurological effects, including seizures and hepatotoxicity.
Precautions:
- Blood Counts: Regular monitoring of blood cell counts is required due to the risk of myelosuppression.
- Infections: Caution in patients with a history of infections or those at risk for opportunistic infections.
- Liver and Renal Function: Regular monitoring of liver and kidney function is recommended.
- Pregnancy and Breastfeeding: Cladribine should be avoided during pregnancy and breastfeeding due to potential fetal harm.
Storage: Store Cladrim in the original packaging at room temperature (20°C to 25°C), away from light and moisture. Keep out of reach of children.
Conclusion: 10mg Cladrim (Cladribine) Injection is a potent treatment for Hairy Cell Leukemia and Multiple Sclerosis. Due to its potential for serious side effects, including bone marrow suppression and infections, regular monitoring and careful administration under medical supervision are essential.
Yes! I am InterestedRequest A Callback
Dexmedetomidine ( Dextomin 200mcg)
Product Price: Rs 550 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 200 mcg |
| Packaging Size | 2 ml |
| Composition | Dexmedetomidine 200 mcg |
| Brand Name | Dextomid |
| Manufacturer By | Neon Laboratories Ltd |
| Treatment | Sedation |
Overview:
Dexmedetomidine, marketed as Dextomin, is a sedative and analgesic agent used primarily for sedation in intensive care and procedural settings. It allows for sedation while enabling patients to remain responsive.
- Sedation for Mechanically Ventilated Patients: Used in the ICU for patients on ventilators.
- Procedural Sedation: Administered during short procedures to keep patients comfortable while allowing for some alertness.
- Postoperative Sedation: Helps in recovery by providing sedation after surgical procedures.
Dexmedetomidine selectively binds to alpha-2 adrenergic receptors in the central nervous system, leading to sedation and analgesia. This action reduces the release of norepinephrine, which helps calm patients while allowing them to respond to commands.
Dosage and Administration- Dosage: The initial infusion rate is usually between 0.2 to 0.7 mcg/kg/hour, tailored to patient needs and response.
- Administration: Administered via intravenous infusion, requiring continuous monitoring of the patient.
Common Side Effects:
- Hypotension (low blood pressure)
- Bradycardia (slow heart rate)
- Drowsiness
- Dry mouth
Serious Side Effects:
- Severe hypotension or bradycardia that may require intervention
- Respiratory depression (though rare)
Regular monitoring of vital signs is crucial, especially blood pressure and heart rate, due to potential cardiovascular effects.
Contraindications- Known hypersensitivity to dexmedetomidine or any of its components.
- Caution is advised for patients with significant cardiovascular disease or hypotension.
Inform your healthcare provider about all medications you are taking, particularly:
- CNS Depressants: Opioids and benzodiazepines, which may enhance sedative effects.
- Other medications that can affect blood pressure or heart rate.
Store Dextomin at room temperature, protected from light and moisture, and keep out of reach of children.
Patient Counseling Information- Usage: Emphasize adherence to prescribed doses and administration guidelines.
- Side Effects: Discuss potential side effects, especially those affecting alertness and cardiovascular stability.
- Discontinuation: Advise against stopping the medication suddenly without consulting a healthcare provider to avoid withdrawal symptoms.
Dextomin (dexmedetomidine 200 mcg) is an effective sedative for various medical scenarios. With careful administration and monitoring, it can significantly improve patient comfort and safety. Always consult a healthcare provider for personalized medical advice and treatment plans.
Yes! I am InterestedRequest A Callback
400mg Bevacizumab Injection
Product Price: Rs 7,250 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 400 mg/16 ml |
| Brand | Bevacirel |
| Manufacturer | Reliance Life Sciences |
| Form | Injection |
| Treatment | Kidney Cancer |
| Composition | Bevacizumab 400mg |
| Storage Condition | 2 DegreeC to 8 DegreeC (36 DegreeF to 46 DegreeF) |
Bavacizumab 400 mg/16 ml Injection (Bevacirel 400 mg/16 ml Injection)
Indications:
Bavacizumab is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. It is typically used in combination with other chemotherapy agents.
Mechanism of Action:
Bavacizumab is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF). By binding to VEGF, it prevents the activation of its receptors, thereby inhibiting angiogenesis (the formation of new blood vessels). This action helps to starve tumors of the necessary blood supply for growth and metastasis.
Dosage and Administration:
- Dosage: The recommended dose of Bavacizumab is typically 5 mg/kg or 10 mg/kg administered via intravenous infusion, depending on the specific cancer type and treatment regimen.
- Administration: Administer as an intravenous infusion over 30 to 90 minutes. Initial doses may be given over a longer period to monitor for infusion reactions.
Contraindications:
- Hypersensitivity to bavacizumab or any component of the formulation.
- Recent surgery or active bleeding disorders.
Warnings and Precautions:
- Monitor for signs of gastrointestinal perforation, hemorrhage, and wound healing complications.
- Use caution in patients with a history of cardiovascular disease.
- Regularly assess blood pressure, as hypertension can occur with treatment.
Side Effects:
Common side effects may include:
- Hypertension
- Fatigue
- Headache
- Nausea
- Diarrhea
- Abdominal pain
Serious side effects can include:
- Gastrointestinal perforations
- Arterial thromboembolic events
- Hemorrhage
- Impaired wound healing
Drug Interactions:
Bavacizumab may interact with other medications that affect blood pressure, anticoagulants, and other anti-cancer therapies. Inform your healthcare provider about all medications you are taking.
Storage:
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Patient Counseling Information:
- Advise patients to report any unusual symptoms, such as severe headaches, visual disturbances, or signs of bleeding.
- Discuss the importance of regular monitoring for blood pressure and other potential side effects.
Conclusion:
Bavacizumab is a targeted therapy that can significantly impact cancer treatment through its mechanism of inhibiting angiogenesis. Ongoing communication with healthcare providers is essential for managing side effects and ensuring the best therapeutic outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
100IU Xeomin Botulinum Neurotoxin Injection
Product Price: Rs 11,650 / PieceGet Best Price
Product Brochure
Product Details:
| Strength | 100 Units |
| Composition | Botulinum Neurotoxin |
| Injectable Form | Lyophilized Powder |
| Packaging Size | Vial |
| Shelf Life | 24 Months |
| Brand Name | Xeomin |
Description:
Botulinum neurotoxin, specifically Xeomin, is a purified protein used for various medical conditions. It works by blocking nerve signals to the muscles, resulting in temporary muscle paralysis. This can help treat specific muscle disorders and reduce symptoms associated with certain neurological conditions.
Indications:
Xeomin is indicated for:
- Chronic Migraines: Reducing the frequency and severity of migraine headaches.
- Cervical Dystonia: Treating severe neck spasms.
- Blepharospasm: Managing involuntary blinking.
- Spasticity: Reducing muscle stiffness in the upper limbs.
Dosage and Administration:
- Dosage: The specific dosage varies based on the condition being treated. For chronic migraines, doses typically range from 155 to 195 units, while cervical dystonia may require doses of 120 units or more, depending on individual response.
- Administration: Administered via intramuscular injection by a qualified healthcare provider. Effects usually take a few days to manifest and can last for several months.
Common Side Effects:
- Pain at the injection site
- Headache
- Muscle weakness
- Dry mouth
- Flu-like symptoms
Precautions:
- Medical History: Inform the healthcare provider of any medical conditions, especially neuromuscular disorders or allergies.
- Pregnancy and Breastfeeding: Consult a healthcare provider before use, as safety during pregnancy and breastfeeding has not been established.
- Avoiding Blood Thinners: Inform the provider about any anticoagulant medications, as these may increase the risk of bruising.
Conclusion:
Botulinum neurotoxin (Xeomin 100 IU) is an effective treatment for various medical conditions, including chronic migraines, cervical dystonia, and spasticity. Administration should be performed by a qualified healthcare professional, with careful monitoring for side effects and individual response to treatment.
Yes! I am InterestedRequest A Callback
Decitabine Lyophilized Injection
Product Price: Rs 1,045 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 50 mg |
| Packaging Type | Vial |
| Brand | Decita |
| Manufacturer | Natco Pharma Ltd |
| Treatment | Blood Cancer and Myelodysplastic Syndromes |
Decitabine Lyophilized Injection (Decita 50 mg Injection)
Indications:
Decitabine is indicated for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in patients who are not candidates for more intensive therapies. It is used to improve hematologic function and reduce the risk of progression.
Mechanism of Action:
Decitabine is a nucleoside analog that inhibits DNA methyltransferase, leading to hypomethylation of DNA. This results in the reactivation of tumor suppressor genes and promotes differentiation and apoptosis in malignant cells, thereby restoring normal hematopoiesis.
Dosage and Administration:
- Dosage: The recommended dose of Decitabine is typically 15 mg/m² administered intravenously over 1 hour on days 1 to 5 of a 28-day treatment cycle. Dosing may be adjusted based on patient response and tolerance.
- Administration: Reconstitute the lyophilized powder with the appropriate diluent. Administer via intravenous infusion.
Contraindications:
- Hypersensitivity to decitabine or any component of the formulation.
- Pregnancy: Decitabine is contraindicated in pregnant women due to potential harm to the fetus.
Warnings and Precautions:
- Bone Marrow Suppression: Monitor blood counts regularly, as decitabine can cause cytopenias. Dose adjustments may be necessary based on blood cell counts.
- Infections: Increased risk of infections; monitor closely for signs of infection and initiate appropriate treatment.
- Liver Function: Monitor liver function tests, particularly in patients with pre-existing liver conditions.
Side Effects:
Common side effects may include:
- Nausea
- Vomiting
- Fatigue
- Diarrhea
- Injection site reactions
Serious side effects can include:
- Severe allergic reactions
- Bone marrow suppression leading to severe cytopenias
- Infections
Drug Interactions:
Decitabine may interact with other medications that can affect blood cell counts. Patients should inform their healthcare provider of all medications they are taking.
Storage:
Store the lyophilized powder at room temperature, between 20°C to 25°C (68°F to 77°F). Once reconstituted, the solution should be used immediately or stored in the refrigerator for a short period as per specific guidelines.
Patient Counseling Information:
- Advise patients to report any signs of infection, unusual bruising or bleeding, or persistent gastrointestinal symptoms.
- Discuss the importance of adhering to the treatment schedule and attending regular follow-up appointments for blood count monitoring.
- Encourage patients to maintain a healthy lifestyle, including proper nutrition and hydration, to support overall health during treatment.
Conclusion:
Decitabine is an effective treatment for myelodysplastic syndromes and acute myeloid leukemia, providing patients with an option to improve hematologic function. Ongoing communication with healthcare providers is essential for managing side effects and ensuring optimal treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
40mg Irinotecan Injection
Product Price: Rs 1,300 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 40 mg/ 2 ml |
| Packaging Type | Vial |
| Brand | Torsirin |
| Storage Condition | Store below 30 DegreeC |
| Manufacturer | Miracalus Pharma Pvt Ltd |
| Treatment | Cancer of Colon and Rectum |
Irinotecan 40 mg/2 ml Injection (Torsirin 40 mg/2 ml Injection)
Indications:
Irinotecan is indicated for the treatment of metastatic colorectal cancer, either as a single agent or in combination with other chemotherapeutic agents. It is particularly effective in patients who have failed prior therapies.
Mechanism of Action:
Irinotecan is a topoisomerase I inhibitor that interferes with DNA replication. It is converted to its active form, SN-38, which binds to and inhibits topoisomerase I, causing DNA damage and apoptosis in cancer cells.
Dosage and Administration:
- Dosage: The recommended dose of Irinotecan is typically 180 mg/m² administered intravenously every two weeks. Dosage may vary based on the specific treatment regimen and patient tolerance.
- Administration: Administer as an intravenous infusion over 30 to 90 minutes. Ensure proper hydration and premedication as necessary.
Contraindications:
- Hypersensitivity to irinotecan or any component of the formulation.
- Diarrhea or bowel obstruction in patients with a history of significant gastrointestinal conditions.
Warnings and Precautions:
- Diarrhea: Monitor closely for severe diarrhea, which can be life-threatening. Administer antidiarrheal agents as needed.
- Bone Marrow Suppression: Regularly assess blood counts, as irinotecan can cause leukopenia, neutropenia, and thrombocytopenia.
- Hepatic Impairment: Dose adjustments may be necessary in patients with liver dysfunction.
Side Effects:
Common side effects may include:
- Diarrhea
- Nausea
- Vomiting
- Fatigue
- Abdominal pain
Serious side effects can include:
- Severe diarrhea
- Neutropenic fever
- Dehydration
Drug Interactions:
Irinotecan may interact with other medications, particularly those affecting liver enzymes and drugs that may exacerbate diarrhea. Patients should inform their healthcare provider of all medications they are taking.
Storage:
Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and moisture. Do not freeze.
Patient Counseling Information:
- Advise patients to report any signs of severe diarrhea, nausea, or unusual bleeding.
- Discuss the importance of adhering to the treatment schedule and attending regular follow-up appointments for blood count monitoring.
- Encourage patients to stay well-hydrated and to maintain a balanced diet during treatment.
Conclusion:
Irinotecan is an effective chemotherapy agent for metastatic colorectal cancer, offering patients a treatment option with a targeted mechanism of action. Continuous communication with healthcare providers is essential for managing side effects and ensuring optimal treatment outcomes. Always consult with a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Phenylephrine Hydrochloride (Phenpres 10mg Injection)
Product Price: Rs 198 / BoxGet Best Price
Product Brochure
Product Details:
| Packaging Size | 1 Ampule of 10ml |
| Strength | 10mg |
| Brand | Phenpres |
| Manufacturer | Neon |
| Composition | Phenylephrine Hcl |
| Form | injection |
| Usage/Application | Hospital |
| Generic Name | Phenylephrine |
Overview: Phenylephrine is a selective alpha-1 adrenergic agonist used primarily as a vasopressor to increase blood pressure and as a decongestant. It is often administered intravenously in clinical settings.
Indications:
- Hypotension: Used to treat acute hypotension, particularly in surgical settings or during anesthesia.
- Nasal Congestion: Sometimes used as a nasal decongestant (though this is more common in oral formulations).
Mechanism of Action: Phenylephrine works by stimulating alpha-1 adrenergic receptors, leading to vasoconstriction (narrowing of blood vessels). This increases systemic vascular resistance and, consequently, blood pressure.
Dosage and Administration:
- Dosage: The usual initial intravenous dose for hypotension is 0.5 to 1 mg, which may be repeated as necessary. Dosage adjustments should be based on the patient’s response.
- Administration: Administered intravenously, typically as a slow injection or continuous infusion. Blood pressure should be monitored closely during administration.
Contraindications:
- Severe hypertension or tachycardia.
- Hypersensitivity to phenylephrine or any component of the formulation.
- Patients taking monoamine oxidase inhibitors (MAOIs).
Warnings and Precautions:
- Use with caution in patients with cardiovascular disease, as it can cause increased blood pressure.
- Monitor for signs of extravasation, which can cause tissue necrosis.
Side Effects:
- Common: Headache, dizziness, anxiety, and palpitations.
- Serious: Hypertension, bradycardia, and potential for reflex bradycardia due to increased blood pressure.
Drug Interactions:
- May interact with other medications affecting blood pressure or those that are MAOIs. Always inform healthcare providers of all medications being taken.
Storage:
- Store at room temperature (20°C to 25°C / 68°F to 77°F) and protect from light. Keep out of reach of children.
Patient Counseling:
- Inform patients about the purpose of the injection and potential side effects.
- Advise them to report any unusual symptoms, especially those related to heart function or blood pressure changes.
Conclusion: Phenylephrine Hydrochloride (Phenpres 10 mg Injection) is an effective agent for managing hypotension and is used in various clinical settings. Proper administration and monitoring are essential for safety and effectiveness. Always consult a healthcare professional for personalized medical advice.
Yes! I am InterestedRequest A Callback
Bonmax PTH 750mcg Solution for Injection
Product Price: Rs 6,500 / PieceGet Best Price
Product Brochure
Product Details:
| Packaging Size | 1X3 ml |
| Strength | 750 mcg/ 3 ml |
| Brand | Bonmax |
| Manufactured By | Zydus Cadila |
| Composition | Teriparatide 750mcg |
| Usage/Application | To Treat Osteoporosis |
Overview: Bonmax is an injectable formulation containing Parathyroid Hormone (PTH), specifically designed for therapeutic use in managing certain bone-related disorders.
Indications:- Osteoporosis: Used in the treatment of osteoporosis in postmenopausal women and in men at high risk for fracture.
- Bone Disorders: May be indicated for specific bone metabolic disorders.
Parathyroid hormone plays a crucial role in regulating calcium levels in the body. It stimulates bone formation by promoting the activity of osteoblasts (bone-forming cells) and increasing calcium absorption in the intestines while reducing renal excretion of calcium.
Dosage and Administration:- Dosage: The typical dose for adults is usually 750 mcg administered subcutaneously once daily. The exact regimen may vary based on the patient's condition and healthcare provider recommendations.
- Administration: Should be administered by a healthcare professional or taught to the patient for self-administration after proper training.
- Common Side Effects: May include:
- Nausea
- Headache
- Dizziness
- Injection site reactions (redness, swelling)
- Serious Side Effects: Rare but can include:
- Hypercalcemia (high calcium levels)
- Allergic reactions
- Hypersensitivity: Should not be used in patients with known allergies to PTH or any components of the formulation.
- Hypercalcemia: Contraindicated in patients with high calcium levels.
- Monitoring: Regular monitoring of calcium levels is essential during treatment to avoid complications.
- Kidney Function: Caution is advised in patients with renal impairment.
Inform your healthcare provider about all medications being taken, especially those affecting calcium metabolism or bone health.
Storage Instructions:Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Bonmax and the importance of adherence to the treatment regimen.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially those related to calcium levels.
- Emphasize the need for follow-up appointments to monitor treatment effectiveness and calcium levels.
Bonmax PTH (750 mcg Solution for Injection) is an effective option for managing osteoporosis and other bone disorders. Always consult healthcare professionals for personalized medical advice and treatment plans.
Yes! I am InterestedRequest A Callback
Razumab 10mg/ml injection
Product Price: Rs 13,500 / VialGet Best Price
Product Brochure
Product Details:
| Strength | 10 mg |
| Packaging Size | 1 Injection in 1 vial |
| Composition | Ranibizumab 10 mg |
| Brand Name | Razumab |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Usage | Diabetic eye disease |
Overview: Razumab is a formulation of Ranibizumab, a monoclonal antibody used primarily for the treatment of various eye conditions. It is most commonly used for wet age-related macular degeneration (AMD) and other retinal disorders.
Indications:- Wet Age-Related Macular Degeneration (AMD): Used to slow vision loss and improve vision in patients with this condition.
- Diabetic Macular Edema (DME): Helps to reduce fluid accumulation in the retina in patients with diabetes.
- Retinal Vein Occlusion (RVO): Effective in treating macular edema secondary to retinal vein occlusion.
Ranibizumab works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes the growth of abnormal blood vessels in the eye. By blocking VEGF, Razumab helps to prevent the formation of these vessels and reduce leakage of fluid into the retina.
Dosage and Administration:- Dosage: The typical initial dose for wet AMD or DME is usually 0.5 mg (0.05 mL) administered via intravitreal injection once a month. The dosing schedule may be adjusted based on the patient’s response and clinical evaluation.
- Administration: The injection should be performed by a qualified healthcare professional in a sterile environment to minimize the risk of infection.
- Common Side Effects: May include:
- Eye discomfort or pain
- Increased intraocular pressure
- Blurred vision
- Serious Side Effects: Rare but can include:
- Eye infections (endophthalmitis)
- Retinal detachment
- Severe allergic reactions
- Hypersensitivity: Known allergy to Ranibizumab or any components of the formulation.
- Active Ocular Infection: Should not be administered in the presence of active ocular infections.
- Monitoring: Patients should be monitored for signs of infection and other complications following the injection.
- Visual Disturbances: Patients should be advised to report any sudden changes in vision.
Inform your healthcare provider about all medications being taken, especially other treatments for eye conditions.
Storage Instructions:Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Keep out of reach of children.
Patient Counseling:- Educate patients on the purpose of Razumab and the injection process.
- Discuss potential side effects and the importance of reporting any unusual symptoms, especially changes in vision.
- Emphasize the need for regular follow-up appointments for ongoing treatment and monitoring.
Razumab (Ranibizumab) Injection 10 mg/mL is an effective treatment for managing conditions like wet AMD and diabetic macular edema. Always consult healthcare professionals for personalized medical advice and treatment plans.
Yes! I am InterestedRequest A Callback
View More